Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Soleno Therapeutics Inc. diskutieren

Soleno Therapeutics Inc.

WKN: A3DS0P / Symbol: SLNO / Name: Soleno Therapeutics / Aktie / Micro Cap /

41,30 €
-1,43 %

Einschätzung Buy
Rendite (%) -23,16 %
Kursziel 105,76
Veränderung
Endet am 20.08.26

Soleno Therapeutics (NASDAQ:SLNO) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $123.00 price target on the stock.
Ratings data for SLNO provided by MarketBeat

Einschätzung Buy
Rendite (%) -25,30 %
Kursziel 91,11
Veränderung
Endet am 27.08.26

Soleno Therapeutics (NASDAQ:SLNO) had its "buy" rating reaffirmed by analysts at Guggenheim. They now have a $106.00 price target on the stock.
Ratings data for SLNO provided by MarketBeat

Soleno Therapeutics (NASDAQ:SLNO) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.
Ratings data for SLNO provided by MarketBeat

Einschätzung Buy
Rendite (%) -17,96 %
Kursziel 106,85
Veränderung
Endet am 07.10.26

Soleno Therapeutics (NASDAQ:SLNO) was given a new $125.00 price target on by analysts at The Goldman Sachs Group, Inc.. They now have a "buy" rating on the stock.
Ratings data for SLNO provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,78 %
Kursziel 64,70
Veränderung
Endet am 18.11.26

Soleno Therapeutics (NASDAQ:SLNO) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $75.00 price target on the stock.
Ratings data for SLNO provided by MarketBeat